Goldman Sachs initiates coverage on recent IPO Accretive Health, Inc. (NYSE: AH) with a Neutral rating and $15 price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE